Literature DB >> 11530809

Waldenström's macroglobulinemia associated with AA amyloidosis.

J Gardyn1, A Schwartz, R Gal, U Lewinski, D Kristt, A M Cohen.   

Abstract

It is widely accepted that amyloidosis in Waldenström's macroglobulinemia (WM) is exclusively due to amyloid light-chain deposition. However, only a small number of previous reports have actually characterized the type of amyloid in WM. We now report the third patient with WM and amyloid A protein (AA) amyloidosis. This patient developed malabsorption, nephrotic syndrome, and orthostatic hypotension. AA was immunohistochemically demonstrated in the rectal biopsy. In conjunction with previous examples of AA amyloidosis, the present report raises the possibility that AA amyloidosis may also occur in WM patients.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11530809     DOI： 10.1007/BF02982553

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  18 in total

1.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

Authors:  S D Yan; H Zhu; A Zhu; A Golabek; H Du; A Roher; J Yu; C Soto; A M Schmidt; D Stern; M Kindy
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.

Authors:  S Ikeda; H Chisuwa; S Kawasaki; J Ozawa; Y Hoshii; T Yokota; T Aoi
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

Review 3.  Amyloidosis: a review of recent diagnostic and therapeutic developments.

Authors:  J D Gillmore; P N Hawkins; M B Pepys
Journal:  Br J Haematol       Date:  1997-11       Impact factor: 6.998

Review 4.  Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.

Authors:  J Ordi; J M Grau; A Junqué; B Nomdedeu; A Palacin; A Cardesa
Journal:  Am J Clin Pathol       Date:  1993-10       Impact factor: 2.493

5.  Immunofluorescence study of "non-idiopathic" renal amyloidosis.

Authors:  C Orfila; J Rakotoarivony; A Segonds; J M Suc
Journal:  Hum Pathol       Date:  1983-04       Impact factor: 3.466

6.  IgM demyelinative neuropathy with amyloidosis and biclonal gammopathy.

Authors:  J Julien; C Vital; J M Vallat; A Lagueny; X Ferrer; C Deminiere; M J Leboutet; C Effroy
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

7.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

8.  Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.

Authors:  R J Strege; W Saeger; R P Linke
Journal:  Virchows Arch       Date:  1998-07       Impact factor: 4.064

Review 9.  Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis.

Authors:  G Faa; P Van Eyken; R De Vos; J Fevery; B Van Damme; J De Groote; V J Desmet
Journal:  J Hepatol       Date:  1991-01       Impact factor: 25.083

10.  Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium.

Authors:  S Urieli-Shoval; P Cohen; S Eisenberg; Y Matzner
Journal:  J Histochem Cytochem       Date:  1998-12       Impact factor: 2.479
View more
  3 in total

1.  AA amyloidosis associated with macroglobulinemia.

Authors:  Raine Tatara; Tadashi Nagai; Hiroyuki Kobayashi; Kaoru Hatano; Takahiro Suzuki; Kazuo Muroi; Keiya Ozawa
Journal:  Int J Hematol       Date:  2010-10-16       Impact factor: 2.490

2.  Tonsil amyloidosis revealing a Waldenström macroglobulinemia.

Authors:  Raida Ben Salah; Sameh Marzouk; Neila Kaddour; Abdelmajid Khabir; Tahia Boudawara; Zouhir Bahloul
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-25       Impact factor: 2.503

Review 3.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.